The Massachusetts Health Policy Commission said it would not resist Beth Israel’s plan, which includes establishing a clinical affiliation with MetroWest and adding both MetroWest and New England Baptist Hospital to its affiliated network of healthcare providers.
While the commission does not have the authority to formally approve or reject proposed deals, it studies the potential impacts such relationships could render on the broader healthcare market. If necessary, the commission refers serious objections to the attorney general, according to the report.
Regarding Beth Israel’s proposed deal, the commission said “small to moderate” increases in medical spending could result, with projections of $4.5 million higher expenditures per year. However, it also said the affiliations carry the potential for savings if Beth Israel’s affiliated network maintains moderate prices and improves the quality of care.
More articles on hospital and physician issues:
UAB Health System unveils physician ratings
Former UCLA medical school dean dies at age 96
San Angelo Community Medical Center, Radiology Partners team up
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
